BioAlliance Pharma receives European patent for acyclovir Lauriad tabletsTuesday, September 7, 2010 @ 11:37PMBioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, today announced the grant of a European patent protecting its product acyclovir Lauriad.
When to Worry About a Cough, from Harvard Men's Health WatchTuesday, September 7, 2010 @ 1:00PMFor most men, chronic coughing raises the specter of cancer. But is cancer really a common cause of a cough that lingers? And if it’s not, what is? The September 2010 issue of Harvard Men’s Health Watch discusses potential causes of this irritating problem.
ASIPP announces educational campaign to improve chronic pain patients’ quality of lifeFriday, September 3, 2010 @ 4:12AMIn recognition of September's designation as National Pain Awareness Month, the American Society of Interventional Pain Physicians (ASIPP) today announced that it is planning a month-long educational campaign to improve the quality of life for the approximately 75 million Americans suffering from acute and chronic pain.
Health CalendarThursday, September 2, 2010 @ 4:26AMFitness
Health CalendarThursday, September 2, 2010 @ 4:11AMAdventist Paulson Rehab Network , 619 Plainfield Road, Willowbrook, offers different fitness and exercise regimens, including pre and post natal exercise, pool class, advanced circuit training program, keep it moving small group exercise class, arthritis foundation aquatic program, aquatic exercise classes and therapeutic massage.
Health CalendarThursday, August 26, 2010 @ 4:40AMBlood Drives
Health CalendarThursday, August 26, 2010 @ 4:10AMThe Village Church of LaGrange Park , 1150 Meadowcrest Road, sponsors a blood drive from 8 a.m. to 2 p.m. Aug. 28. Participating donors will receive a $15 Target gift card while supplies last (one per person).
Health notesThursday, August 26, 2010 @ 12:24AMLake Health offers child/parent classes
Pfizer:Cancer Pill Sutent Fails Endpoint In Lung-Cancer TrialMonday, August 23, 2010 @ 5:09PMPfizer:Cancer Pill Sutent Fails Endpoint In Lung-Cancer Trial